For more lab news and updates, please visit our Lab Blog!
Combination therapy for KIT-mutant mast cells: Targeting constitutive NFAT and KIT activity. Mol Cancer Ther. 2014 Sep 24 (Click here to view)
Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract. J Am Acad Dermatol. 2014 May 17. (Click here to view)
Regorafenib for treatment of advanced gastrointestinal stromal tumors. Expert Opin Pharmacother. 2014 Mar;15(4):549-58. (Click here to view)
KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation. J Clin Oncol. 2014 Mar 31. [Epub ahead of print]. (Click here to view)
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial. J Clin Oncol. 2014 May 20;32(15):1563-70. (Click here to view)
Novel Mutations in Neuroendocrine Carcinoma of the Breast: Possible Therapeutic Targets. Diagn Mol Pathol. 2014 Feb 24. [Epub ahead of print]. (Click here to view)